Arbutus Biopharma Corporation (ABUS)

Last Closing Price: 4.07 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Arbutus Biopharma Corporation (ABUS) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.30M
$59.12M
Cost of Goods Sold
--
$0.30M
$10.79M
$-10.49M
$69.61M
$59.12M
$59.12M
--
--
--
--
$-10.49M
$-10.48M
198.68M
199.63M
$0.30
$0.30
Balance Sheet Financials
$339.57M
--
$0.13M
$339.70M
$241.93M
--
$12.02M
$253.95M
$85.75M
$85.75M
$85.75M
199.28M
Cash Flow Statement Financials
$225.68M
$1.04M
$19.47M
$18.01M
$264.19M
$246.18M
$4.17M
--
--
Fundamental Metrics & Ratios
1.40
--
--
--
--
100.00%
-3509.70%
-3509.70%
--
19770.90%
19770.90%
$225.68M
--
--
--
0.00
--
0.38
238.39
--
--
--
--
$0.43
$1.13
$1.13